Clinical Drug Experience Knowledgebase

alectinib (alecensa) (2 trials)

abiraterone (zytiga) (1 trial)

acetaminophen (tylenol) (1 trial)

aldesleukin (proleukin) (2 trials)

aldoxorubicin (1 trial)

anastrozole (arimidex) (2 trials)

bevacizumab (avastin) (5 trials)

bleomycin (blenoxane) (2 trials)

cabazitaxel (jevtana kit) (1 trial)

candesartan (atacand) (1 trial)

capecitabine (xeloda) (12 trials)

carboplatin (paraplatin) (22 trials)

carmustine (bicnu) (1 trial)

chlorambucil (Leukeran) (1 trial)

cisplatin (platinol) (15 trials)

cyclophosphamide (cytoxan) (13 trials)

cytarabine (cytosar-u) (1 trial)

dacarbazine (dtic-dome) (1 trial)

docetaxel (taxotere) (16 trials)

doxorubicin (Doxil) (7 trials)

enzalutamide (xtandi) (2 trials)

epirubicin (ellence) (2 trials)

erlotinib (tarceva) (2 trials)

etoposide (vepesid) (3 trials)

exemestane (aromasin) (1 trial)

filgrastim (neupogen) (1 trial)

floxuridine (fudr) (1 trial)

fludarabine (fludara) (2 trials)

fluorouracil (efudex) (5 trials)

gemcitabine (gemzar) (5 trials)

ifosfamide (ifex) (1 trial)

imiquimod (aldara) (1 trial)

ipilimumab (yervoy) (10 trials)

letrozole (femara) (1 trial)

lidocaine (xylocaine) (1 trial)

melphalan (alkeran) (1 trial)

mesna (mesnex) (1 trial)

miltefosine (impavido) (1 trial)

naltrexone (revia) (1 trial)

oxaliplatin (eloxatin) (5 trials)

oxygen (1 trial)

paclitaxel (taxol) (17 trials)

paromomycin (humatin) (1 trial)

pemetrexed (alimta) (3 trials)

peripheral blood hematopoietic cell (1 trial)

pertuzumab (perjeta) (2 trials)

procarbazine (matulane) (1 trial)

sargramostim (leukine) (1 trial)

sodium stibogluconate (1 trial)

tamoxifen (nolvadex) (3 trials)

thiotepa (5 trials)

trastuzumab (herceptin) (5 trials)

urea (1 trial)

vinblastine (velban) (1 trial)

vincristine (oncovin) (2 trials)

4sc-202 (2 trials)

afatinib (gilotrif) (2 trials)

amphinex (1 trial)

atezolizumab (tecentriq) (5 trials)

avelumab (bavencio) (2 trials)

axitinib (inlyta) (2 trials)

celecoxib (celebrex) (1 trial)

cemiplimab (libtayo) (1 trial)

cetuximab (erbitux) (3 trials)

cobimetinib (cotellic) (3 trials)

cp-506 (1 trial)

cypep-1 (1 trial)

dabrafenib (tafinlar) (2 trials)

dacomitinib (vizimpro) (1 trial)

daratumumab (darzalex) (1 trial)

darleukin (1 trial)

durvalumab (imfinzi) (3 trials)

everolimus (zortress) (1 trial)

fluticasone (cutivate) (1 trial)

fulvestrant (faslodex) (1 trial)

galunisertib (1 trial)

gefitinib (iressa) (1 trial)

irinotecan (Camptosar) (2 trials)

l19il2 (1 trial)

lapatinib (tykerb) (1 trial)

lenvatinib (lenvima) (1 trial)

ly3200882 (1 trial)

mk-1775 (1 trial)

monalizumab (1 trial)

nilotinib (tasigna) (1 trial)

niraparib (zejula) (1 trial)

nivolumab (opdivo) (12 trials)

ny-eso-1 t cells (1 trial)

olaparib (lynparza) (7 trials)

osimertinib (tagrisso) (1 trial)

panitumumab (vectibix) (1 trial)

pazopanib (votrient) (3 trials)

pbmcs (1 trial)

pd-0325901 (1 trial)

pembrolizumab (keytruda) (6 trials)

personalized neoantigen vaccine (1 trial)

propranolol (inderal) (1 trial)

regorafenib (stivarga) (1 trial)

ritonavir (Norvir) (6 trials)

selumetinib (1 trial)

talimogene laherparepvec (Imlygic) (1 trial)

tcr transduced t-cells (1 trial)

temoporfin (1 trial)

trametinib (mekinist) (3 trials)

trastuzumab emtansine (kadcyla) (1 trial)

tremelimumab (2 trials)

vemurafenib (zelboraf) (3 trials)

vinorelbine (navelbine) (1 trial)

vismodegib (erivedge) (1 trial)

vorinostat (zolinza) (1 trial)

azd1390 (1 trial)

azd7648 (1 trial)

bupropion (wellbutrin) (1 trial)

cobicistat (stribild) (1 trial)

eribulin (halaven) (1 trial)

lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)

ly3214996 (1 trial)

rmc-4630 (1 trial)

sch66336 (1 trial)

sunitinib (sutent) (1 trial)

taselisib (1 trial)

bintrafusp alfa (1 trial)

midazolam (versed) (1 trial)

morphine (1 trial)